Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
Fatiha M. Benslimane, Hebah A. Al-Khatib, Ola Al-Jamal, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Hiam Chemaitelly, Patrick Tang, Mohammad R. Hasan, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 553
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 19, pp. 1804-1816
Open Access | Times Cited: 362
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 214
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
JAMA (2021) Vol. 326, Iss. 19, pp. 1930-1930
Open Access | Times Cited: 161
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant
Adeel A. Butt, Soha R. Dargham, Srusvin Loka, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e361-e367
Open Access | Times Cited: 117
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar
Adeel A. Butt, Soha R. Dargham, Hiam Chemaitelly, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 197-197
Open Access | Times Cited: 101
Duration of immune protection of SARS-CoV-2 natural infection against reinfection
Hiam Chemaitelly, Nico Nagelkerke, Houssein H. Ayoub, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 90
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 87
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 596-608.e17
Closed Access | Times Cited: 71
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature (2025)
Open Access | Times Cited: 2
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
PLoS Medicine (2021) Vol. 18, Iss. 12, pp. e1003879-e1003879
Open Access | Times Cited: 64
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e944-e955
Open Access | Times Cited: 59
COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
Adeel A. Butt, Soha R. Dargham, Patrick Tang, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 57
Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections and severe COVID-19 in Qatar
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 40
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EBioMedicine (2023) Vol. 95, pp. 104734-104734
Open Access | Times Cited: 32
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
American Journal of Epidemiology (2023) Vol. 193, Iss. 6, pp. 883-897
Open Access | Times Cited: 25
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1188-e1191
Open Access | Times Cited: 48
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
Houssein H. Ayoub, Ghina R. Mumtaz, Shaheen Seedat, et al.
Global Epidemiology (2021) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 40
Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 36
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 32
Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
Heba N. Altarawneh, Hiam Chemaitelly, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
Elias Tayar, Sami Abdeen, Muna Abed Alah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 2, pp. 250-256
Open Access | Times Cited: 29
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top